-based Stryker, introduced InSpace in India, for the treatment of massive irreparable rotator cuff tears (MIRCTs). This biodegradable balloon implant offers a minimally invasive arthroscopic solution for one of the most common causes of shoulder dysfunction.
The InSpace implant is designed to restore the subacromial space without requiring sutures or fixation devices. It has demonstrated efficacy in improving shoulder motion and function, providing surgeons with a nother option in their shoulder care. Aman Rishi, vice president and general manager for Stryker in India, emphasized the nature of this technology, highlighting its potential to offer early functional recovery and pain relief for patients.
The company clains that InSpace implant is backed by 35 peer-reviewed clinical articles and has been used in 41,000 procedures globally. Its clinically proven advantages include:
1. A less invasive surgical solution compared to treatments requiring fixation devices or grafts.
2. Significant improvement in shoulder motion and function.
3. Increased range of motion compared to partial repair surgery.
4. Comparable long-term safety and effectiveness results to partial repair, extending to two years.
5. High clinical success rate, exceeding 87% at two years, in patients 65 and older.
The InSpace system is specifically indicated for patients 65 years and older with massive, irreparable full-thickness rotator cuff tears due to trauma or degradation.
Stryker clians that InSpace represents a significant step forward in orthopedic care, offering new hope for patients suffering from this debilitating condition and expanding the treatment options available to surgeons in India.
Last updated: December 26th, 2025
